Wells Fargo Upgrades Praxis Precision Medicine to Overweight, Raises Price Target to $509

Benzinga · 4d ago
Wells Fargo analyst Benjamin Burnett upgrades Praxis Precision Medicine (NASDAQ:PRAX) from Equal-Weight to Overweight and raises the price target from $343 to $509.